CORT113176: Clinical Trials

1 trial of CORT113176, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 active not recruiting. 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 21Active not recruiting 1

Follow CORT113176: new trials by email Literature Review of CORT113176 trials Research Report on CORT113176

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Dazucorilant in Patients With Amyotrophic Lateral Sclerosis
Dazucorilant 300 mg, Dazucorilant 150 mg, Placebo - Amyotrophic Lateral Sclerosis
Phase 2Active not recruitingCorcept Therapeutics2792022-11-152026-09-24

Conditions studied

Amyotrophic Lateral Sclerosis (1)

Sponsors

Corcept Therapeutics (1)

Countries

Belgium (1)  ·  Canada (1)  ·  France (1)  ·  Germany (1)  ·  Ireland (1)  ·  Netherlands (1)  ·  Poland (1)  ·  Spain (1)  ·  United Kingdom (1)  ·  United States (1)

Top investigators

Sophia Majeed, PharmD, PhD (1)